Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 28, 2019 11:06 ET | Source: Karolinska Development AB (publ)

Karolinska Developments årsstämma 2019

STOCKHOLM, SVERIGE – 28 juni 2019. Vid Karolinska Development AB:s (publ) (”Karolinska Development” eller ”Bolaget”) årsstämma som hölls den 28 juni 2019 beslutade aktieägarna, följande: ...
June 28, 2019 11:06 ET | Source: Karolinska Development AB (publ)

Karolinska Development´s Annual General Meeting 2019

STOCKHOLM, SVERIGE – June 28, 2019. At the Annual General Meeting of Karolinska Development AB (publ) (“Karolinska Development” or the “Company”) held June 28, 2019, the following resolutions were...
June 28, 2019 07:56 ET | Source: Karolinska Development AB (publ)

Uppdatering avseende teckningsåtaganden i Karolinska Developments riktade nyemission till bolagets konvertibelinnehavare

STOCKHOLM, SVERIGE – 28 juni 2019. Den 29 maj 2019 offentliggjorde Karolinska Development AB (publ) (”Karolinska Development” eller ”Bolaget”) att styrelsen för Bolaget hade beslutat, under...
June 28, 2019 07:56 ET | Source: Karolinska Development AB (publ)

Update concerning subscription undertakings in Karolinska Development’s directed share issue to the holders of the Company’s convertible loan

STOCKHOLM, SWEDEN – 28 June 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) (“Karolinska Development” or the “Company”) announced on 29 May 2019 that the Board of Directors of the Company has...
June 27, 2019 12:00 ET | Source: Karolinska Development AB (publ)

Karolinska Development avyttrar sitt ägande i Pharmanest för 23 mkr

STOCKHOLM, SVERIGE – 27 juni 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att bolaget har avyttrat hela sitt ägande i portföljbolaget Pharmanest AB. Även KCIF Co-investment...
June 27, 2019 12:00 ET | Source: Karolinska Development AB (publ)

Karolinska Development sells its ownership in Pharmanest for SEK 23 million

STOCKHOLM, SWEDEN – 27 June 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that the company has sold its entire ownership in the portfolio company Pharmanest AB. KCIF...
June 26, 2019 13:08 ET | Source: Karolinska Development AB (publ)

Offentliggörande av de fullständiga villkoren i Karolinska Developments riktade nyemission till bolagets konvertibelinnehavare

STOCKHOLM, SVERIGE – 26 juni 2019. Den 29 maj 2019 offentliggjorde Karolinska Development AB (publ) (”Karolinska Development” eller ”Bolaget”) att styrelsen för Bolaget hade beslutat, under...
June 26, 2019 13:08 ET | Source: Karolinska Development AB (publ)

Announcement of the final terms and conditions of Karolinska Development’s directed share issue to the holders of the Company’s convertible loan

STOCKHOLM, SWEDEN – 26 June 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) (“Karolinska Development” or the “Company”) announced on 29 May 2019 that the Board of Directors of the Company has...
June 04, 2019 05:57 ET | Source: Karolinska Development AB (publ)

Aktiemarknadsnämnden beviljar Sino Biopharmaceutical dispens från budplikt

STOCKHOLM, SVERIGE - 4 juni 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) meddelar idag att Aktiemarknadsnämnden beviljar dispens till Sino Biopharmaceutical från budplikt i samband med...
June 04, 2019 05:57 ET | Source: Karolinska Development AB (publ)

The Swedish Securities Council grants Sino Biopharmaceutical exemption from the mandatory bid obligation

STOCKHOLM, SWEDEN – 4 June 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the Swedish Securities Council grants Sino Biopharmaceutical exemption from the mandatory bid...